World Health Organization Guidelines on Medicines for Diabetes Treatment Intensification: Commentary From the American College of Physicians High Value Care Committee

Ann Intern Med. 2018 Sep 18;169(6):398-400. doi: 10.7326/M18-1148. Epub 2018 Sep 4.

Authors

Linda L Humphrey¹, Devan Kansagara², Amir Qaseem³; High Value Care Committee of the American College of Physicians; Robert Centor, Douglas M DeLong, Heather E Gantzer, Carrie A Horwitch, Janet A Jokela, Joseph Ming Wah Li, Robert H Lohr, Ana María López, Robert M McLean

Collaborators

High Value Care Committee of the American College of Physicians:
Amir Qaseem, George M Abraham, Robert Centor, Douglas M DeLong, Heather E Gantzer, Carrie A Horwitch, Linda L Humphrey, Janet A Jokela, Joseph Ming Wah Li, Robert H Lohr, Ana María López, Robert M McLean

Affiliations

¹ Oregon Health & Science University, Portland, Oregon (L.L.H.).
² Oregon Health & Science University and Veterans Affairs Medical Center, Portland, Oregon (D.K.).
³ American College of Physicians, Philadelphia, Pennsylvania (A.Q.).

PMID: 30178054
DOI: 10.7326/M18-1148

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Administration, Oral
Diabetes Mellitus, Type 2*
Humans
United States
World Health Organization